Chromosome Analysis - Bone Marrow

A chromosome analysis of bone marrow (cytogenetic testing) examines the number and structure of chromosomes in marrow cells to detect abnormalities such as translocations, deletions or aneuploidy. It helps diagnose and classify blood cancers and bone marrow disorders, guide prognosis and treatment, and monitor response. The test uses a marrow aspirate or biopsy; cells are cultured, stained and analyzed microscopically, often supplemented by FISH or molecular tests.

Genetic testing of bone marrow examines DNA and RNA from marrow cells to detect chromosomal abnormalities and gene mutations using methods such as karyotyping (cytogenetics), FISH, PCR, and next‑generation sequencing. It identifies translocations, deletions, and point mutations common in leukemias and myelodysplastic syndromes, informs diagnosis, prognosis, and targeted therapy choices, and requires a bone marrow aspirate or biopsy sample.

Yes. Bone marrow contains many nucleated cells (hematopoietic stem cells, white blood cell precursors, megakaryocytes, stromal cells) that have nuclei and chromosomes (DNA). However, mature human red blood cells and platelets lack nuclei and therefore do not contain chromosomes. Bone marrow is the primary site of blood cell production, so most developing blood cells in marrow carry chromosomes until they fully mature.

The purpose of chromosome analysis is to identify changes in chromosome number or structure to diagnose genetic conditions (such as Down, Turner, Klinefelter), investigate unexplained developmental delay, congenital anomalies, infertility or recurrent miscarriage, and assess prenatal health. Results guide clinical management, prognosis and genetic counselling for families, and help decide on further testing or specialist care.

Chromosome analysis timing varies by method. Traditional karyotyping typically takes about 7–14 days because cells must be cultured. Rapid aneuploidy tests (FISH or QF‑PCR) can yield results in 1–3 days. Chromosomal microarray often requires 7–21 days. Prenatal sample type (amniocentesis vs CVS) and laboratory workload can extend turnaround; complex or confirmatory testing may take longer.

Chromosome analysis (karyotyping or genetic testing) reveals chromosomal sex by identifying sex chromosomes—typically XX (female) or XY (male)—and detects variations (e.g., XO, XXY) or mosaicism. It indicates genetic sex but may not match a person's physical characteristics or gender identity, and some intersex conditions or chromosomal anomalies can complicate straightforward classification.